These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29667263)

  • 1. Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies.
    Pye SR; Sheppard T; Joseph RM; Lunt M; Girard N; Haas JS; Bates DW; Buckeridge DL; van Staa TP; Tamblyn R; Dixon WG
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):781-788. PubMed ID: 29667263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology.
    Jani M; Yimer BB; Selby D; Lunt M; Nenadic G; Dixon WG
    Pharmacoepidemiol Drug Saf; 2023 Jun; 32(6):651-660. PubMed ID: 36718594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.
    Suissa S; Moodie EE; Dell'Aniello S
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):459-468. PubMed ID: 27610604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Drug Exposure Definitions on Observed Associations in Pharmacoepidemiology Research.
    Eskin M; Eurich DT; Simpson SH
    J Popul Ther Clin Pharmacol; 2018 Mar; 25(1):e39-e52. PubMed ID: 29949683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.
    Gamble JM; Chibrikov E; Twells LK; Midodzi WK; Young SW; MacDonald D; Majumdar SR
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):43-52. PubMed ID: 27865756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
    Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F
    BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).
    Lum KJ; Newcomb CW; Roy JA; Carbonari DM; Saine ME; Cardillo S; Bhullar H; Gallagher AM; Lo Re V
    Eur J Clin Pharmacol; 2017 Jan; 73(1):115-123. PubMed ID: 27787616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More realistic power estimation for new user, active comparator studies: an empirical example.
    Gokhale M; Buse JB; Pate V; Marquis MA; Stürmer T
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):462-6. PubMed ID: 26360635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example.
    Secrest MH; Platt RW; Reynier P; Dormuth CR; Benedetti A; Filion KB
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():35-44. PubMed ID: 31486165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?
    Karp I; Sivaswamy A; Booth C
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):489-499. PubMed ID: 30779266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.
    Filion KB; Douros A; Azoulay L; Yin H; Yu OH; Suissa S
    Br J Clin Pharmacol; 2019 Oct; 85(10):2378-2389. PubMed ID: 31276600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes.
    Salvo F; Faillie JL
    Therapie; 2019 Apr; 74(2):255-260. PubMed ID: 30470475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
    Davis JM; Maradit Kremers H; Crowson CS; Nicola PJ; Ballman KV; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Mar; 56(3):820-30. PubMed ID: 17330254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).
    Carbonari DM; Saine ME; Newcomb CW; Blak B; Roy JA; Haynes K; Wood J; Gallagher AM; Bhullar H; Cardillo S; Hennessy S; Strom BL; Lo Re V
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):999-1003. PubMed ID: 26213344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.
    Lin TC; Solomon DH; Tedeschi SK; Yoshida K; Kao Yang YH
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort study.
    van Sijl AM; Boers M; Voskuyl AE; Nurmohamed MT
    PLoS One; 2014; 9(1):e87965. PubMed ID: 24498229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective cohort analysis of hypoglycaemic and cardiovascular agent use in young adults in the Irish primary care setting.
    Grimes RT; Bennett K; Hoey H; Tilson L; Henman MC
    Ir J Med Sci; 2017 May; 186(2):461-470. PubMed ID: 27534545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
    Douros A; Dell'Aniello S; Yu OHY; Filion KB; Azoulay L; Suissa S
    BMJ; 2018 Jul; 362():k2693. PubMed ID: 30021781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes.
    Douros A; Abrahami D; Yin H; Yu OHY; Renoux C; Hudson M; Azoulay L
    Epidemiology; 2018 Nov; 29(6):904-912. PubMed ID: 30028343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.